Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_1
5
100%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Other(5)

Detailed Status

unknown5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 15 (100.0%)

Trials by Status

unknown5100%

Recent Activity

0 active trials
Showing 5 of 5
unknownphase_1

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

NCT02873442
unknownphase_1

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

NCT02873416
unknownphase_1

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

NCT02862613
unknownphase_1

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

NCT02862587
unknownphase_1

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

NCT02862561

Clinical Trials (5)

Showing 5 of 5 trials
NCT02873442Phase 1

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Unknown
NCT02873416Phase 1

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

Unknown
NCT02862613Phase 1

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Unknown
NCT02862587Phase 1

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Unknown
NCT02862561Phase 1

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Unknown

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5